Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery

American Heart Journal

Volumn 158, Issue 4, 2009, Pages 680-687

  Katz, Jason N ^a,b   Stebbins, Amanda L ^b   Alexander, John H ^b,c   Reynolds, Harmony R ^d   Pieper, Karen S ^b   Ruzyllo, Witold ^e   Werdan, Karl ^f   Geppert, Alexander ^g   Dzavik, Vladimir ^h   Van de Werf, Frans ⁱ   Hochman, Judith S ^d  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d NEW YORK UNIVERSITY   (United States)

^e INSTITUTE OF CARDIOLOGY   (Poland)

^f MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^g WILHELMINEN HOSPITAL   (Austria)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DOBUTAMINE; DOPAMINE; FIBRINOGEN RECEPTOR ANTAGONIST; MILRINONE; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; NORADRENALIN; PHENYLEPHRINE; PLACEBO;

ACUTE HEART INFARCTION; ADULT; AGED; AORTA BALLOON; ARTICLE; CARDIOGENIC SHOCK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DOUBLE BLIND PROCEDURE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; MORTALITY; MULTICENTER STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; VASCULAR PATENCY;

AGED; ARGININE; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NITRIC OXIDE SYNTHASE; NOREPINEPHRINE; ONTARIO; PROGNOSIS; PROSPECTIVE STUDIES; SHOCK, CARDIOGENIC; SURVIVAL RATE; TIME FACTORS; UNITED STATES; VASCULAR PATENCY; VASOCONSTRICTOR AGENTS;

EID: 70349205513     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.08.005     Document Type: Article

References (27)

1. Babaev A., Frederick P.D., Pasta D.J., et al. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 294 (2005) 448-454
2. Fang J., Mensah G.A., Alderman M.H., et al. Trends in acute myocardial infarction complicated by cardiogenic shock, 1979-2003, United States. Am Heart J 152 (2006) 1035-1041
3. Hochman J.S., Sleeper L.A., Webb J.G., et al. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA 295 (2006) 2511-2515
4. Sleeper L.A., Jacobs A.K., LeJemtel T.H., et al. A mortality model and severity scoring system for cardiogenic shock complicating acute myocardial infarction. Circulation 102 (2000) II-795
5. Katayama T., Nakashima H., Takagi C., et al. Predictors of mortality in patients with acute myocardial infarction and cardiogenic shock. Circ J 69 (2005) 83-88
6. Tarantini G., Ramondo A., Isabella G., et al. Pressure response to vasopressors and mortality after direct angioplasty for cardiogenic shock. Int J Cardiol 94 (2004) 197-202
7. Mehta R.H., Califf R.M., Yang Q., et al. Impact of initial heart rate and systolic blood pressure on relation of age and mortality among fibrinolytic-treated patients with acute ST-elevation myocardial infarction presenting with cardiogenic shock. Am J Cardiol 99 (2007) 793-796
8. Klein L.W., Shaw R.E., Krone R.J., et al. Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model. Am J Cardiol 96 (2005) 35-41
9. Singh M., White J., Hasdai D., et al. Long-term outcome and its predictors among patients with ST-segment elevation myocardial infarction complicated by shock. Insights from the GUSTO-1 trial. J Am Coll Cardiol 50 (2007) 1752-1758
10. Hochman J.S., Sleeper L.A., Webb J.G., et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 341 (1999) 625-634
11. Webb J.G., Lowe A.M., Sanborn T.A., et al. Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial. J Am Coll Cardiol 42 (2003) 1380-1386
12. Bengtson J.R., Kaplan A.J., Pieper K.S., et al. Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era. J Am Coll Cardiol 20 (1992) 1482-1489
13. The TRIUMPH Investigators. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. JAMA 297 (2007) 1657-1666
14. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
15. Stone C.J., and Koo C.Y. Proc Stat Comp Sect Am Statist Assoc (1985), Amer Statist Assoc, Washington, DC 45-48
16. Dzavik V., Cotter G., Reynolds H.R., et al. Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging study. Eur Heart J 28 (2007) 1109-1116
17. Schreiber W., Herkner H., Koreny M., et al. Predictors of survival in unselected patients with acute myocardial infarction requiring continuous catecholamine support. Resuscitation 55 (2002) 269-276
18. Valente S., Lazzeri C., Vecchio S., et al. Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock. Int J Cardiol 114 (2007) 176-182
19. Müllner M., Urbanek B., Havel C., et al. Vasopressors for shock. Cochrane Database Syst Rev (2004) CD003709
20. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 110 (2004) 588-636
21. Samadi A., Le Feuvre C., Allali Y., et al. Medium-term survival after primary angioplasty for myocardial infarction complicated by cardiogenic shock after the age of 75 years. Arch Cardiovasc Dis 101 (2008) 175-180
22. Marenzi G., Moltrasio M., Assanelli E., et al. Impact of cardiac and renal dysfunction on inhospital morbidity and mortality of patients with acute myocardial infarction undergoing primary angioplasty. Am Heart J 153 (2007) 755-762
23. Koreny M., Karth G.D., Geppert A., et al. Prognosis of patients who develop acute renal failure during the first 24 hours of cardiogenic shock after myocardial infarction. Am J Med 112 (2002) 115-119
24. Uchino S., Kellum J.A., Bellomo R., et al. Acute renal failure in critically ill patients. A multinational, multicenter study. JAMA 294 (2005) 813-818
25. Vis M.M., Sjauw K.D., van der Schaaf R.J., et al. In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes. Am Heart J 154 (2007) 1184-1190
26. Picard M.H., Davidoff R., Sleeper L.A., et al. Echocardiographic predictors of survival and response to early revascularization in cardiogenic shock. Circulation 107 (2003) 279-284
27. Hochman J.S. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation 107 (2003) 2998-3002